Abstract
a phase 1, first in human (FIH) study of adenovirally transduced autologous macrophages engineered to contain an anti-HER2 chimeric antigen receptor (CAR) in subjects with HER2 overexpressing solid tumors
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have